Poul Lykkesfeldt is an author and adviser with more than 35 years of experience in business-oriented communications, capital markets, equity research, corporate transactions (IPO, ECM, DCM, M&A), as well as the advice of boards of directors and senior management.

Lykkesfeldt has deep insight in the financial and life science (pharmaceuticals and biotech) sectors but has worked with more than 20 other industries over the years.